Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.

BACKGROUND Prognosis of potentially curable (M0), completely resected gastric cancer is primarily determined by pathologic T and N staging criteria. The optimal regional dissection extent during gastrectomy for gastric adenocarcinoma continues to be debated. METHODS A gastric cancer data set was created through structured queries to the Surveillance, Epidemiology, and End Results database (1973 to 1999). Relationships between the number of lymph nodes (LNs) examined and survival were analyzed for the stage subgroups T1/2N0, T1/2N1, T3N0, and T3N1. RESULTS In every stage subgroup, overall survival was highly dependent on the number of LNs examined. Multivariate prognostic variables in the T1/2N0M0 subgroup were number of LNs examined, age (for both, P < .0001), race (P = .0004), sex (P = .0006), and tumor size (P = .02). A linear trend for superior survival based on more LNs examined could be confirmed for all four stage subgroups. Baseline model-predicted 5-year survival with only one LN examined was 56% (T1/2N0), 35% (T1/2N1), 29% (T3N0), or 13% (T3N1). For every 10 extra LNs dissected, survival improved by 7.6% (T1/2N0), 5.7% (T1/2N1), 11% (T3N0), or 7% (T3N1). A cut-point analysis yielded the greatest survival difference at 10 LNs examined but continued to detect significantly superior survival differences for cut points at up to 40 LNs, always in favor of more LNs examined. CONCLUSION Although the impact of stage migration versus improved regional disease control cannot be separated on basis of the available information, the data provide support in favor of extended lymphadenectomy during potentially curative gastrectomy for gastric cancer.

[1]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[2]  K. Karakostas,et al.  Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: A prospective with quality control 10-year follow-up study , 2001, British Journal of Cancer.

[3]  P. Hermanek,et al.  Classification of regional lymph node metastasis from gastric carcinoma , 1998, Cancer.

[4]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[5]  Tomasz Burzykowski,et al.  Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? , 2002, Journal of surgical oncology.

[6]  J. Siewert,et al.  Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992 , 1993, Cancer.

[7]  K. Geisinger,et al.  Lymphatic Mapping for Gastric Adenocarcinoma , 2002, The American surgeon.

[8]  S. Hundahl,et al.  The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy , 2000, Cancer.

[9]  J. Chmiel,et al.  Cancer of the stomach. A patient care study by the American College of Surgeons. , 1993, Annals of surgery.

[10]  M. Pike,et al.  Conservatism of the approximation sigma (O-E)2-E in the logrank test for survival data or tumor incidence data. , 1973, Biometrics.

[11]  E. Hannan,et al.  The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. , 2002, Surgery.

[12]  C. Belluco,et al.  Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience , 2003, Annals of Surgical Oncology.

[13]  Y. Kodera,et al.  The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. , 1998, Journal of the American College of Surgeons.

[14]  R. Schwarz,et al.  Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy , 2002, Annals of surgical oncology.

[15]  Hongbo Zhu,et al.  Lymphatic mapping and sentinel node biopsy in gastric cancer. , 2004, American journal of surgery.

[16]  A. Mushlin,et al.  Influence of Surgical Subspecialty Training on In-Hospital Mortality for Gastrectomy and Colectomy Patients , 2003, Annals of surgery.

[17]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[18]  D. Klimstra,et al.  Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?: An Analysis of 1,038 Patients , 2000, Annals of surgery.

[19]  J. Faivre,et al.  How many nodes must be examined to accurately stage gastric carcinomas? , 2002, Cancer.

[20]  D. Cox.  Regression Models and Life-Tables , 1972 .

[21]  S. Hundahl,et al.  Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment , 2002, Annals of Surgical Oncology.

[22]  Scott A. Hundahl,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2001, The New England journal of medicine.

[23]  K. Choe,et al.  Influence of the number of lymph nodes examined on staging of gastric cancer , 2001, The British journal of surgery.

[24]  D. Winchester,et al.  The national cancer data base report on gastric carcinoma , 1997, Cancer.

[25]  M. Tachibana,et al.  Body Mass Index Determines the Success of Lymph Node Dissection and Predicts the Outcome of Gastric Carcinoma Patients , 2000, Oncology.

[26]  D. Gouma,et al.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  P. Fayers,et al.  Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.

[28]  F. Roviello,et al.  The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients , 2002, British Journal of Cancer.

[29]  M. Sasako,et al.  New method to evaluate the therapeutic value of lymph node dissection for gastric cancer , 1995, The British journal of surgery.

[30]  J. Siewert,et al.  Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. , 1998, Annals of surgery.

[31]  M. Kattan,et al.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  S. Kitano,et al.  Perigastric lymph node status as a prognostic indicator in patients with gastric cancer , 1998, The British journal of surgery.

[33]  B. Millat,et al.  Appropriate Gastric Resection with Lymph Node Dissection for Early Gastric Cancer , 2004, Annals of Surgical Oncology.

[34]  Y. Kodera,et al.  Extended lymph node dissection in gastric carcinoma: where do we stand after the Dutch and British randomized trials? , 2002, Journal of the American College of Surgeons.

[35]  H. Höfler,et al.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases , 1996 .